News Articles on ULURU Inc.

ULURU Inc. Reports Third Quarter 2009 Financial Results

ADDISON, Texas, Nov. 16 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) today announced its financial results for t
http://www.bioportfolio.com/news/ULURU-Inc.-Reports-Third-Quarter-2009-Financial.html - Monday November 16 2009

ULURU Inc. to Raise $1.5 Million in Registered Direct Offering

ADDISON, Texas, Nov. 12 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU), a specialty pharmaceutical company fo
http://www.bioportfolio.com/news/ULURU-Inc.-to-Raise-%241.5-Million-in-Registered.html - Thursday November 12 2009

ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update

ADDISON, Texas, Nov. 3 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that it has scheduled a conferen
http://www.bioportfolio.com/news/ULURU-Inc.-Announces-Conference-Call-to-Discuss.html - Tuesday November 3 2009

ULURU Inc. Announces Poster Presentation of Dr. Gregory Bohn

ULURU Inc. Announces Poster Presentation on the Use of Altrazeal(TM) in Home Care

The poster details the performance
http://www.bioportfolio.com/news/ULURU-Inc.-Announces-Poster-Presentation-on-the.html - Thursday October 22 2009

ULURU Inc. Announces Extensive Clinical Evidence Presented at the 24th Annual 'Clinical Symposium on Advances in Skin and Wound Care'

    --  Controlled clinical study showing a statistically significan
http://www.bioportfolio.com/news/ULURU-Inc.-Announces-Extensive-Clinical-Evidence.html  - Wednesday October 21 2009
ULURU Inc. Presents Data on Negative Pressure Related to Altrazeal(TM) at the Diabetic Limb Salvage Conference in Washington, D.C.
ADDISON, Texas, Sept. 24 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) announced today the presentation 
http://www.bioportfolio.com/news/ULURU_Inc._Presents_Data_on_Negative_Pressure.html  - Thursday September 24 2009
ULURU Inc. to Present Altrazeal(TM) Clinical Evidence at the American Podiatric Medical Association (APMA) Annual Scientific Meeting in Toronto, Canada
ADDISON, Texas, July 29, /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) announced today that the applicat
http://www.bioportfolio.com/news/ULURU_Inc._to_Present_Altrazeal%28TM%29_Clinical.html  - Wednesday July 29 2009
ULURU Inc. Announces Revised Business Plan
 
ADDISON, Texas, June 30 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) ULURU Inc. today announced that it has res
http://www.bioportfolio.com/news/ULURU_Inc._Announces_Revised_Business.html  - Tuesday June 30 2009
ULURU Discussions to Acquire York Pharma, plc Are Currently Terminated
ADDISON, Texas, June 24 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) today announced that at this time discussions to ac
http://www.bioportfolio.com/news/ULURU_Discussions_to_Acquire_York_Pharma%2C_plc_Are.html  - Wednesday June 24 2009
ULURU Inc. Reports First Quarter 2009 Financial Results
    Contact: Company
    Renaat Van den Hooff
    President & CEO
    Terry K. Wallberg
    Vice President & CFO
    (214) 905-5145



       
http://www.bioportfolio.com/news/ULURU_Inc._Reports_First_Quarter_2009_Financial.html  - Friday May 15 2009
ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2009 and to Provide a Business Update
ADDISON, Texas, May 13 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that it has scheduled a confere
http://www.bioportfolio.com/news/ULURU_Inc._Announces_Conference_Call_to_Discuss.html  - Wednesday May 13 2009
ULURU Inc. Announces Altrazeal(TM) Clinical Experience Published in the International Wound Journal
ADDISON, Texas, May 5 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE AMEX: ULU) announced today that clinical evidence utilizing Altrazeal(TM) Nanoflex
http://www.bioportfolio.com/news/ULURU_Inc._Announces_Altrazeal%28TM%29_Clinical.html  - Tuesday May 5 2009
Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Conference 2009
ADDISON, Texas, April 1 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) announced 
http://www.bioportfolio.com/news/Altrazeal%28TM%29_Clinical_Evidence_to_be_Presented.html  - Wednesday April 1 2009
ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 2008
    Contact: Company
    Renaat Van den Hooff
    President & CEO
    Terry K. Wallberg
    Vice President & CFO
    (214) 905-5145

http://www.bioportfolio.com/news/ULURU_Inc._Reports_Financial_Results_for_Fourth.html - Monday March 30 2009

ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2008 and to Provide a Business Update

ADDISON, Texas, March 25 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that it has scheduled a conference cal
http://www.bioportfolio.com/news/ULURU_Inc._Announces_Conference_Call_to_Discuss.html - Wednesday March 25 2009

ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009

ADDISON, Texas, March 18 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) announced that clinical evidence on the treatment of d
http://www.bioportfolio.com/news/ULURU_Inc._to_Present_Altrazeal%28TM%29_Clinical.html - Wednesday March 18 2009

ULURU Inc. Announces Appointment of Jeffrey A. Niezgoda, M.D., as Chairman of Scientific Advisory Board

ADDISON, Texas, March 13 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced the appointment of Jeffrey A. Niezgoda
http://www.bioportfolio.com/news/ULURU_Inc._Announces_Appointment_of_Jeffrey_A..html - Friday March 13 2009

ULURU Inc. Announces Senior Management Change

- PRESIDENT AND CEO RESIGNS -

ADDISON, Texas, March 9 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today anno
http://www.bioportfolio.com/news/ULURU_Inc._Announces_Senior_Management.html - Monday March 9 2009

ULURU Inc. Announces Signing of European Agreement With Meda AB for the Marketing of Amlexanox 5 Percent Paste and OraDisc(TM) A

ADDISON, Texas, Nov. 17 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced the signing of a License Agreement with Meda AB
http://www.bioportfolio.com/news/ULURU_Inc._Announces_Signing_of_European.html - Monday November 17 2008

ULURU Inc. Reports Financial Results for Third Quarter of 2008

ADDISON, Texas, Nov. 10 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE: ULU) today announced its financial results for the third quarter ended Sept
http://www.bioportfolio.com/news/ULURU_Inc._Reports_Financial_Results_for_Third.html - Monday November 10 2008

ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2008 and to Provide a Business Update

ADDISON, Texas, Nov. 4 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE: ULU) today announced that it has scheduled a conference call to discuss the
http://www.bioportfolio.com/news/ULURU_Inc._Announces_Conference_Call_to_Discuss.html - Tuesday November 4 2008

ULURU Inc. Announces the Launch of the Altrazeal(TM) Website

- New Site Provides Extensive Information to Patients and Physicians -

ADDISON, Texas, Nov. 4 /PRNewswire
http://www.bioportfolio.com/news/ULURU_Inc._Announces_the_Launch_of_the.html - Tuesday November 4 2008

ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver

ADDISON, Texas, Oct. 21 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that it has commenced a clinical study to ev
http://www.bioportfolio.com/news/ULURU_Inc._Announces_the_Commencement_of_First.html - Tuesday October 21 2008

ULURU Inc. to Host Satellite Symposium at the 23rd Annual 'Clinical Symposium on Advances in Skin & Wound Care'

ADDISON, Texas, Oct. 13 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that it will be sponsoring a Satellite Sympo
http://www.bioportfolio.com/news/ULURU_Inc._to_Host_Satellite_Symposium_at_the.html - Monday October 13 2008

ULURU Inc. to Present at the Thomas Weisel Partners Healthcare Conference 2008

ADDISON, Texas, Sept. 4 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) today announced that it is scheduled to present at the Thomas Weisel P
http://www.bioportfolio.com/news/ULURU_Inc._to_Present_at_the_Thomas_Weisel.html - Thursday September 4 2008

ULURU Inc. Reports Second Quarter 2008 Financial Results

ADDISON, Texas, Aug. 11 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) today reported financial results for the second quarter ended June 30,
http://www.bioportfolio.com/news/ULURU_Inc._Reports_Second_Quarter_2008_Financial.html - Monday August 11 2008

ULURU Inc. Announces Conference Call to Discuss Financial Results for the Second Quarter Ended June 30, 2008 and Provide a Business Update

ADDISON, Texas, Aug. 5 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) today announced that it has scheduled a conference call to discuss the
http://www.bioportfolio.com/news/ULURU_Inc._Announces_Conference_Call_to_Discuss.html - Tuesday August 5 2008

ULURU Inc. Announces Update on Recent Development

ADDISON, Texas, July 8 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) today announced that it has scheduled a conference call to provide an u
http://www.bioportfolio.com/news/ULURU_Inc._Announces_Update_on_Recent.html - Tuesday July 8 2008